Amin Sobh

6PUBLICATIONS
44CO-AUTHORS
GlycoconjugatesMolecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 13, 2026
Selective Glucocorticoid Receptor Modulators of Immune Checkpoint Function.

Robin R Kobylski, Charles K Min, Jerome C Nwachukwu

|Apr 10, 2024
NSD2 drives t(4;14) myeloma cell dependence on adenylate kinase 2 by diverting one-carbon metabolism to the epigenome.

Amin Sobh, Elena Encinas, Alisha Patel

|Sep 16, 2022
Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AML.

Nam H K Nguyen, Roya Rafiee, Abderrahmane Tagmount

|Oct 20, 2021
Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-XL-Specific Degrader DT2216.

Dinesh Thummuri, Sajid Khan, Patrick W Underwood

|Jun 23, 2021
Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma.

Lenka Besse, Andrej Besse, Sara C Stolze

|Jun 09, 2020
Genetic screens reveal CCDC115 as a modulator of erythroid iron and heme trafficking.

Amin Sobh, Alex Loguinov, Jie Zhou

Pageof 1

Frequent Collaborators

3 joint publications

Christopher D Vulpe

2 joint publications

Jonathan D Licht

1 joint publications

Sara C Stolze

1 joint publications

Esther A Zaal